Jesse Novak

4.0k total citations · 1 hit paper
17 papers, 2.1k citations indexed

About

Jesse Novak is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Jesse Novak has authored 17 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Jesse Novak's work include Renal cell carcinoma treatment (4 papers), Epigenetics and DNA Methylation (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Jesse Novak is often cited by papers focused on Renal cell carcinoma treatment (4 papers), Epigenetics and DNA Methylation (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Jesse Novak collaborates with scholars based in United States, China and Denmark. Jesse Novak's co-authors include Sabina Signoretti, Jean‐Christophe Pignon, Eric A. Severson, Taiwen Li, Hui Shen, X. Shirley Liu, Jun S. Liu, Haoquan Zhao, Jon C. Aster and Bo Li and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

Jesse Novak

17 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comprehensive analyses of tumor immunity: implications for cancer immunotherapy

2016 1.6k citations Bo Li, Eric A. Severson et al. Genome biology profile →

Peers

Jesse Novak

PRM

ONCOL

IMMUN

Jean‐Christophe Pignon United States

Haoquan Zhao United States

Ching Ngar Wong Hong Kong

Jia Zhong China

Xuanwen Bao China

Jaclyn Sceneay Australia

Amanda Khuong United States

Karen Zwaenepoel Belgium

Alan T. Yeo United States

Yeqing Angela Yang United States

Jean‐Christophe Pignon United States

Jesse Novak

1.2k ×1.0

1.0k ×1.2

PRM

1.0k ×1.3

ONCOL

661 ×0.9

675 ×1.3

IMMUN

Citations per year, relative to Jesse Novak Jesse Novak (= 1×) peers Jean‐Christophe Pignon

Countries citing papers authored by Jesse Novak

Since Specialization

Citations

This map shows the geographic impact of Jesse Novak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jesse Novak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jesse Novak more than expected).

Fields of papers citing papers by Jesse Novak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jesse Novak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jesse Novak. The network helps show where Jesse Novak may publish in the future.

Co-authorship network of co-authors of Jesse Novak

This figure shows the co-authorship network connecting the top 25 collaborators of Jesse Novak. A scholar is included among the top collaborators of Jesse Novak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jesse Novak. Jesse Novak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Yau, Annie, et al.. (2022). A Medical Student-Run Telehealth Primary Care Clinic During the COVID-19 Pandemic: Maintaining Care for the Underserved. Journal of Primary Care & Community Health. 13. 4267734991–4267734991. 6 indexed citations

Gonzales, Kevin Andrew Uy, Lisa Polak, Irina Matos, et al.. (2021). Stem cells expand potency and alter tissue fitness by accumulating diverse epigenetic memories. Science. 374(6571). eabh2444–eabh2444. 76 indexed citations

Novak, Jesse, Sanjeethan C. Baksh, & Elaine Fuchs. (2021). Dietary interventions as regulators of stem cell behavior in homeostasis and disease. Genes & Development. 35(3-4). 199–211. 22 indexed citations

He, Ye, Miklós Dióssy, Christian Bowman-Colin, et al.. (2021). BRCA1/Trp53 heterozygosity and replication stress drive esophageal cancer development in a mouse model. Proceedings of the National Academy of Sciences. 118(41). 9 indexed citations

Baksh, Sanjeethan C., Shiri Gur‐Cohen, Brian Hurwitz, et al.. (2020). Extracellular serine controls epidermal stem cell fate and tumour initiation. Nature Cell Biology. 22(7). 779–790. 82 indexed citations

Kaelin, William G., Jinfang Zhang, Hiroyuki Inuzuka, et al.. (2020). pVHL suppresses kinase activity of Akt in a proline-hydroxylation-dependent manner. UNC Libraries. 1 indexed citations

Hu, Junhui, Shiruyeh Schokrpur, Maani M. Archang, et al.. (2018). A Non-integrating Lentiviral Approach Overcomes Cas9-Induced Immune Rejection to Establish an Immunocompetent Metastatic Renal Cancer Model. Molecular Therapy — Methods & Clinical Development. 9. 203–210. 31 indexed citations

McBrayer, Samuel K., Benjamin A. Olenchock, Diana D. Shi, et al.. (2018). Autochthonous tumors driven by Rb1 loss have an ongoing requirement for the RBP2 histone demethylase. Proceedings of the National Academy of Sciences. 115(16). E3741–E3748. 12 indexed citations

Gào, Xīn, Opeyemi A. Jegede, Paul J. Catalano, et al.. (2018). Comprehensive Genomic Profiling of Metastatic Tumors in a Phase 2 Biomarker Study of Everolimus in Advanced Renal Cell Carcinoma. Clinical Genitourinary Cancer. 16(5). 341–348. 4 indexed citations

10.

Pignon, Jean‐Christophe, Opeyemi A. Jegede, Christine E. Horak, et al.. (2018). Evaluation of predictive biomarkers for nivolumab in metastatic clear cell renal cell carcinoma (mccRCC) using RECIST and immune-related (IR) RECIST.. Journal of Clinical Oncology. 36(6_suppl). 619–619. 2 indexed citations

11.

Chakraborty, Abhishek A., Eijiro Nakamura, Jun Qi, et al.. (2017). HIF activation causes synthetic lethality between the VHL tumor suppressor and the EZH1 histone methyltransferase. Science Translational Medicine. 9(398). 36 indexed citations

12.

Huang, Franklin W., Mikael L. Rinne, Stephanie A. Mullane, et al.. (2017). Cell-free tumor DNA and TERT promoter mutations in bladder cancer.. Journal of Clinical Oncology. 35(6_suppl). 353–353. 1 indexed citations

13.

Wankowicz, Stephanie A., Lillian Werner, Anna Orsola, et al.. (2017). Differential Expression of PD-L1 in High Grade T1 vs Muscle Invasive Bladder Carcinoma and its Prognostic Implications. The Journal of Urology. 198(4). 817–823. 32 indexed citations

14.

Pignon, Jean‐Christophe, Opeyemi A. Jegede, Kathleen M. Mahoney, et al.. (2017). Impact of immune checkpoint protein expression in tumor cells and tumor infiltrating CD8⁺ T cells on clinical benefit from PD-1 blockade in metastatic clear cell renal cell carcinoma (mccRCC).. Journal of Clinical Oncology. 35(6_suppl). 477–477. 9 indexed citations

15.

Li, Bo, Eric A. Severson, Jean‐Christophe Pignon, et al.. (2016). Comprehensive analyses of tumor immunity: implications for cancer immunotherapy. Genome biology. 17(1). 174–174. 1612 indexed citations breakdown →

16.

Guo, Jianping, Abhishek A. Chakraborty, Pengda Liu, et al.. (2016). pVHL suppresses kinase activity of Akt in a proline-hydroxylation–dependent manner. Science. 353(6302). 929–932. 155 indexed citations

17.

Wang, Xiaoli, Fei Ye, Joseph Tripodi, et al.. (2014). JAK2 inhibitors do not affect stem cells present in the spleens of patients with myelofibrosis. Blood. 124(19). 2987–2995. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact